search button

Role of RLIP76 in doxorubicin resistance in lung cancer (Review)

  • Authors:
    • Rit Vatsyayan
    • Pankaj Chaudhary
    • Poorna Chandra Rao Lelsani
    • Preeti Singhal
    • Yogesh C. Awasthi
    • Sanjay Awasthi
    • Sharad S. Singhal

  • View Affiliations

  • Published online on: June 1, 2009     https://doi.org/10.3892/ijo_00000279
  • Pages: 1505-1511
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Lung cancer is still a major cause of cancer deaths in spite of considerable efforts in its systemic therapy. Chemotherapy, along with local irradiation is frequently employed but as a palliative therapy. Inherent and acquired resistance in NSCLC and SCLC towards chemotherapeutic agents further makes chemotherapy an incommodious problem. The resistance mechanisms responsible for inherent DOX-resistance of NSCLC and acquired DOX-resistance in SCLC have been the subject of numerous investigations. This review will focus on the recent studies done for understanding the mechanism(s) of inherent and acquired resistance in NSCLC and SCLC and how these can be exploited for the future development of more effective novel biologic agents for the treatment of lung cancer.

Related Articles

Journal Cover

June 2009
Volume 34 Issue 6

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 4.5
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 9.6
  • CiteScore Rank: Q1: #66/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.88
  • SCImago Journal Rank (SJR): 1.099
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Vatsyayan R, Chaudhary P, Lelsani PC, Singhal P, Awasthi YC, Awasthi S and Singhal SS: Role of RLIP76 in doxorubicin resistance in lung cancer (Review). Int J Oncol 34: 1505-1511, 2009.
APA
Vatsyayan, R., Chaudhary, P., Lelsani, P.C., Singhal, P., Awasthi, Y.C., Awasthi, S., & Singhal, S.S. (2009). Role of RLIP76 in doxorubicin resistance in lung cancer (Review). International Journal of Oncology, 34, 1505-1511. https://doi.org/10.3892/ijo_00000279
MLA
Vatsyayan, R., Chaudhary, P., Lelsani, P. C., Singhal, P., Awasthi, Y. C., Awasthi, S., Singhal, S. S."Role of RLIP76 in doxorubicin resistance in lung cancer (Review)". International Journal of Oncology 34.6 (2009): 1505-1511.
Chicago
Vatsyayan, R., Chaudhary, P., Lelsani, P. C., Singhal, P., Awasthi, Y. C., Awasthi, S., Singhal, S. S."Role of RLIP76 in doxorubicin resistance in lung cancer (Review)". International Journal of Oncology 34, no. 6 (2009): 1505-1511. https://doi.org/10.3892/ijo_00000279